In addition, Nestin has been implicated in aggressive, poorly differentiated liver cancer in humans and mice (Tschaharganeh et al. 2014) and found elevated particularly in cHCC–ICC (Xue et al. 2019). Here, NES is linked to intrahepatic cholangiocarcinoma.